Behzad Aghazadeh is venBio Select Advisor's portfolio manager. venBio returned more than 60% during the first 11 months of 2014.
| Fund Name: | VenBio Select Advisor |
| Manager | Behzad Aghazadeh |
| Portfolio Value | $11,136,250,185 |
| Change This QTR | +1.10% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | UTHR | 2,777,777 | $1,505,082,912 | +6% | 13.52% | ||
| 2. | Ascendis Pharma | 5,111,111 | $1,363,235,526 | NEW | 12.24% | ||
| 3. | KRYS | 2,888,888 | $1,073,713,003 | 9.64% | |||
| 4. | MDGL | 1,833,333 | $984,408,154 | +1% | 8.84% | ||
| 5. | ARGX | 1,000,000 | $927,770,000 | 8.33% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2026-08-14 | ||||
| 2026-08-14 | ||||
| 2026-08-14 | ||||
| 2026-07-30 | ||||
| 2026-05-15 |
Hedge Fund Resource Center